Rhaeos: Funding, Investors & Team (Oct 2026)
The first wearable shunt monitor in the world, Rhaeos, uses a cutting-edge thermal biosensor to enhance the quality of care for hydrocephalus patients. Rhaeos was created at Northwestern University in partnership with Dr. John Rogers, the McCormick School of Engineering, the Feinberg School of Medicine, and the Kellogg School of Management. It is a unique example of a multidisciplinary translational effort addressing a critical clinical need.
Rhaeos has raised $12.0M across 2 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Oct 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rhaeos Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Rhaeos Funding Rounds
Rhaeos raised $10.5M in a Series A announced in Feb 2023.
8 months later, an undisclosed round of $1.5M was announced in Oct 2023.
Rhaeos Founders and Leadership Team
No contact details are on record for this team yet.
Rhaeos Funding Compared to Other Biotechnology Startups
Rhaeos' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rhaeos in Biotechnology and Evanston
Companies Similar to Rhaeos
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Rhaeos Funding FAQs
What does Rhaeos do?
The first wearable shunt monitor in the world, Rhaeos, uses a cutting-edge thermal biosensor to enhance the quality of care for hydrocephalus patients. Rhaeos was created at Northwestern University in partnership with Dr. John Rogers, the McCormick School of Engineering, the Feinberg School of Medicine, and the Kellogg School of Management. It is a unique example of a multidisciplinary translational effort addressing a critical clinical need.
How much funding has Rhaeos raised?
Rhaeos has raised $12.0M across 2 rounds on record. The most recent is an undisclosed round of $1.5M announced in Oct 2023.
When did Rhaeos last raise funding?
Rhaeos' most recent funding round on record is an undisclosed round of $1.5M, announced in Oct 2023.
Who founded Rhaeos?
FundedIQ lists Siddharth Krishnan (Founder) at Rhaeos.
Who is the CEO of Rhaeos?
Anna Lisa Somera is listed as CEO at Rhaeos.
Where is Rhaeos headquartered?
Rhaeos is based in Evanston, Illinois, United States.
How many employees does Rhaeos have?
Rhaeos is in the 1-10 employee band.
How does Rhaeos' funding compare to other Biotechnology startups?
Rhaeos' latest round of $1.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rhaeos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rhaeos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.